Table 2.
Effects of different treatments on the incidence of diarrhea and on fecal scores at 12 h p.i.
| Group | Incidence of diarrhea (%) |
Fecal score (12 h p.i.) | |||
| 12 h | 24 h | 48 h | 96 h | ||
| A | 80 | 0 | 0 | 0 | 1.33±0.49d |
| B | 0 | 0 | 0 | ||
| C | 90 | 30 | 10 | 0 | 1.58±0.50b |
| D | 80 | 30 | 10 | 0 | 1.31±0.47d |
| E | 50 | 0 | 0 | 0 | 1.39±0.50d |
| F | 100 | 90 | 20 | 10 | 1.48±0.63c |
| G | 100 | 60 | 50 | 50 | 1.73±0.64a |
A, CM-Pal prevention group; B, uninfected group; C, Pal group; D, montmorillonite powder group; E, CM-Pal treatment group; F, gentamicin group; G, no treatment group. Within columns, different superscripts (a–d) indicate a significant difference (P<0.05)